Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.362 USD | -0.28% | -5.97% | -17.71% |
May. 16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
May. 15 | AIM ImmunoTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 172K | Sales 2025 * | 1.78M | Capitalization | 18.56M |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -25M | EV / Sales 2024 * | 108 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.4 x |
P/E ratio 2024 * |
-0.82
x | P/E ratio 2025 * |
-0.8
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.07% |
Latest transcript on AIM ImmunoTech Inc.
1 day | -0.28% | ||
1 week | -5.97% | ||
1 month | -7.18% | ||
3 months | -9.64% | ||
6 months | -24.58% | ||
Current year | -17.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
William Mitchell
CHM | Chairman | 89 | 98-06-30 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.362 | -0.28% | 243,492 |
24-05-30 | 0.363 | +4.01% | 151,033 |
24-05-29 | 0.349 | -0.29% | 517,671 |
24-05-28 | 0.35 | -9.09% | 352,628 |
24-05-24 | 0.385 | -3.00% | 164,681 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.71% | 18.56M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- AIM Stock